Alpha Cognition Inc. - Common Stock (ACOG)

5.7500
-0.1000 (-1.71%)
NASDAQ · Last Trade: Mar 14th, 8:20 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Solas Capital Loads Up On Kyndryl With 407,000 Shares Boughtfool.com
This technology firm delivers IT infrastructure and managed solutions to major enterprises across multiple global industries.
Via The Motley Fool · March 5, 2026
Alpha Cognition Inc. (NASDAQ:ACOG) Reports Q3 2025 Revenue Beat and Strong Commercial Progress for ZUNVEYLchartmill.com
Alpha Cognition's Q3 2025 results beat revenue estimates by 37% on strong sales of its Alzheimer's drug, ZUNVEYL, showing significant commercial momentum.
Via Chartmill · November 13, 2025
Earnings Scheduled For November 13, 2025benzinga.com
Via Benzinga · November 13, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · September 30, 2025
Earnings Scheduled For August 14, 2025benzinga.com
Via Benzinga · August 14, 2025
Earnings Scheduled For May 15, 2025benzinga.com
Via Benzinga · May 15, 2025
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · April 24, 2025
Earnings Scheduled For March 31, 2025benzinga.com
Via Benzinga · March 31, 2025
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analystbenzinga.com
HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.
Via Benzinga · March 18, 2025
This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga.com
Via Benzinga · March 18, 2025
Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer's Drug In Chinabenzinga.com
Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits for blast-related brain injuries.
Via Benzinga · January 8, 2025
Invizyne Technologies Jumps After IPOtalkmarkets.com
Invizyne Technologies opened on Nov. 13 at $11.10. Shares gained as much as 13% following the company's $15 million initial public offering. Additionally, Alpha Cognition opened on Nov. 12 at $7.00.
Via Talk Markets · November 17, 2024